SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-20-008441
Filing Date
2020-04-24
Accepted
2020-04-24 16:00:32
Documents
3
Period of Report
2020-06-08
Effectiveness Date
2020-04-24

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A vxrt20200422_def14a.htm DEF 14A 665923
2 proxy01.jpg GRAPHIC 200354
3 proxy02.jpg GRAPHIC 182457
  Complete submission text file 0001437749-20-008441.txt   1194603
Mailing Address 290 UTAH AVE., SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address 290 UTAH AVE., SUITE 200 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35285 | Film No.: 20814879
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences